Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.

Sparshatt, A; Taylor, D; Patel, M X; Kapur, S

Sparshatt, A; Taylor, D; Patel, M X; Kapur, S.

Affiliation

Sparshatt A; Pharmacy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London SE5 8AZ, UK.

Acta Psychiatr Scand ; 120(6): 416-28, 2009 Dec.

Article in En | MEDLINE | ID: mdl-19573049

Subject(s)

Psychotic Disorders/drug therapy; Psychotic Disorders/physiopathology; Schizophrenia/drug therapy; Schizophrenia/physiopathology; Sulpiride/analogs & derivatives; Amisulpride; Antipsychotic Agents/administration & dosage; Antipsychotic Agents/blood; Antipsychotic Agents/pharmacology; Antipsychotic Agents/therapeutic use; Basal Ganglia Diseases/chemically induced; Clinical Trials as Topic; Drug Monitoring; Humans; Receptors, Dopamine/metabolism; Sulpiride/administration & dosage; Sulpiride/adverse effects; Sulpiride/blood; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Sulpiride Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Acta Psychiatr Scand Year: 2009 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google